ArticleAmerican health & drug benefits2017

Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm.

Jordan S Orange et al.PubMed ↗Full text ↗

No numbers read from the abstract.